Agaris™ – Scaling Plant Biotechnology for Sustainable Agroforestry
Agaris™, developed by Crown Organogenesis Protocols Inc., is a cutting-edge plant biotechnology platformdesigned to transform elite plant genetics into high-value, sustainable agroforestry assets.
Our mission is to bridge science and agriculture by delivering genetically verified, disease-free plantlets that support the predictable production of aromatic crops, timber, and essential oils for global markets.
Mission
To enable sustainable, high-value agroforestry systems through biotechnology, providing:
- Elite plantlets: Tissue culture propagation ensures genetic fidelity and disease-free production.
- Structured plantations: Lab-to-Land™ protocols integrate nursery optimization, permanent and host plant systems, and performance monitoring.
- Sustainable value creation: ESG-aligned practices, biodiversity preservation, and traceable supply chains.
- Global market integration: Connecting high-value tropical crops with premium international fragrance, wellness, and essential oil industries.
Vision
To be a global leader in tropical plant biotechnology, providing scalable, reliable, and sustainable solutions for the next generation of high-value agroforestry.
Core Value Proposition
- Science-Driven: Advanced organogenesis and tissue culture protocols ensure elite genotype propagation.
- Predictable Performance: Lab-to-Land™ deployment guarantees survival, growth, and yield metrics.
- Sustainable & Traceable: Full genetic and plantation traceability aligns with global ESG and certification standards.
- Market-Ready Crops: Agarwood, sandalwood, nutmeg, ylang-ylang, and other high-value species tailored for international supply chains.
Agaris™ is not just a plantlet platform—it is a holistic ecosystem where biotechnology, sustainable agroforestry, and global market opportunity converge, delivering tangible, high-value plantation assets for investors, farmers, and commercial partners alike.